Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92942631 | 9294263 | 1 | I | 201303 | 20130423 | 20130516 | 20130516 | PER | US-009507513-1305USA005394 | MERCK | 40.00 | YR | F | Y | 0.00000 | 20130516 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92942631 | 9294263 | 1 | PS | MIRALAX | 1 | ORAL | UNK, UNKNOWN | D | 22015 | POWDER FOR ORAL SOLUTION | |||||||||
| 92942631 | 9294263 | 2 | SS | COLACE | 1 | UNK, UNKNOWN | D | 0 | |||||||||||
| 92942631 | 9294263 | 3 | SS | FIBER (UNSPECIFIED) | 1 | UNK, UNKNOWN | D | 0 | |||||||||||
| 92942631 | 9294263 | 4 | SS | MINERAL OIL | 1 | UNK, UNKNOWN | D | 0 | |||||||||||
| 92942631 | 9294263 | 5 | C | SEROQUEL | 1 | 100 MG, QAM | U | 0 | 100 | MG | QD | ||||||||
| 92942631 | 9294263 | 6 | C | SEROQUEL | 1 | 300 MG, HS | U | 0 | 300 | MG | QD | ||||||||
| 92942631 | 9294263 | 7 | C | XANAX | 1 | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||||
| 92942631 | 9294263 | 8 | C | LORAZEPAM | 1 | UNK | U | 0 | |||||||||||
| 92942631 | 9294263 | 9 | C | TRAZODONE HYDROCHLORIDE | 1 | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||||
| 92942631 | 9294263 | 10 | C | AMBIEN | 1 | UNK, UNKNOWN | U | 0 | |||||||||||
| 92942631 | 9294263 | 11 | C | OXYCODONE | 1 | UNK, UNKNOWN | U | 0 | |||||||||||
| 92942631 | 9294263 | 12 | C | OXYCODONE | 1 | U | 0 | ||||||||||||
| 92942631 | 9294263 | 13 | C | SOMA | 1 | UNK, UNKNOWN | U | 0 | |||||||||||
| 92942631 | 9294263 | 14 | C | EFEXOR | 1 | UNK, QAM | U | 0 | QD | ||||||||||
| 92942631 | 9294263 | 15 | C | VITAMIN D (UNSPECIFIED) | 1 | UNK, UNKNOWN | U | 0 | |||||||||||
| 92942631 | 9294263 | 16 | C | Vitamin B12 | 1 | UNK, UNKNOWN | U | 0 | |||||||||||
| 92942631 | 9294263 | 17 | C | BIOTIN | 1 | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92942631 | 9294263 | 1 | Faeces hard |
| 92942631 | 9294263 | 2 | Faeces hard |
| 92942631 | 9294263 | 3 | Faeces hard |
| 92942631 | 9294263 | 4 | Faeces hard |
| 92942631 | 9294263 | 5 | Insomnia |
| 92942631 | 9294263 | 6 | Anxiety |
| 92942631 | 9294263 | 7 | Product used for unknown indication |
| 92942631 | 9294263 | 8 | Product used for unknown indication |
| 92942631 | 9294263 | 9 | Insomnia |
| 92942631 | 9294263 | 10 | Insomnia |
| 92942631 | 9294263 | 11 | Intervertebral disc protrusion |
| 92942631 | 9294263 | 12 | Spinal osteoarthritis |
| 92942631 | 9294263 | 13 | Product used for unknown indication |
| 92942631 | 9294263 | 14 | Depression |
| 92942631 | 9294263 | 15 | Product used for unknown indication |
| 92942631 | 9294263 | 16 | Product used for unknown indication |
| 92942631 | 9294263 | 17 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92942631 | 9294263 | Abdominal distension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92942631 | 9294263 | 1 | 201303 | 0 | ||
| 92942631 | 9294263 | 2 | 201303 | 0 |